Fig. 4
From: Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Comparison with the rate of decline in FVC over 6 months between the antifibrotic drug-treated group and the non-treated group in patients with JRS stage I with oxygen desaturation on the 6MWT or those with JRS stage I with GAP stage II/III. (A) In patients with JRS stage I with oxygen desaturation on the 6MWT. (B) In patients with JRS stage I with GAP stage II/III